Literature DB >> 20490336

Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.

Shouying Du1, Hooman H Rashidi, Dzung T Le, Thomas J Kipps, H Elizabeth Broome, Huan-You Wang.   

Abstract

Systemic mastocytosis with associated clonal haematological non-mast cell lineage disease (SM-AHNMD) is a heterogeneous group of mast cell disorders with different clinical, pathologic and underlying molecular characteristics. While myelomonocytic/myeloid neoplasia overwhelmingly predominates the AHNMD component, lymphoproliferative disorders rarely occur as an AHNMD component of SM-AHNMD. Here we report two cases of SM-AHNMD, in which the AHNMD component is chronic lymphocytic leukemia in one case, and concurrent chronic lymphocytic leukemia as well as plasma cell myeloma in another case. To the best of our knowledge, this is the first case report of SM-AHNMD with chronic lymphocytic leukemia and plasma cell dyscrasia simultaneously.

Entities:  

Keywords:  Chronic lymphocytic leukemia; systemic mastocytosis; systemic mastocytosis with associated clonal haematological non-mast cell lineage disease

Mesh：

Substances：

Year:  2010        PMID： 20490336      PMCID： PMC2872752     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN： 1936-2625


  25 in total

1.  Systemic mast cell disease associated with B-chronic lymphocytic leukemia.

Authors:  M A Sanz; D Valcárcel; A Sureda; L Muñoz; I Espinosa; J Nomdedeu; J Sierra
Journal:  Haematologica       Date:  2001-10       Impact factor: 9.941

2.  Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).

Authors:  Karl Sotlar; Sema Colak; Anja Bache; Sabina Berezowska; Manuela Krokowski; Burkhard Bültmann; Peter Valent; Hans-Peter Horny
Journal:  J Pathol       Date:  2010-04       Impact factor: 7.996

3.  Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies.

Authors:  B S Wilkins; S L Buchan; J Webster; D B Jones
Journal:  Histopathology       Date:  2001-08       Impact factor: 5.087

Review 4.  Mast cell growth, differentiation, and death.

Authors:  Michael F Gurish; Joshua A Boyce
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

5.  Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies.

Authors:  Animesh Pardanani; Ken-Hong Lim; Terra L Lasho; Christy Finke; Rebecca F McClure; Chin-Yang Li; Ayalew Tefferi
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

6.  Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens.

Authors:  H-P Horny; K Lange; K Sotlar; P Valent
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

7.  Significance of systemic mast cell disease with associated hematologic disorders.

Authors:  W D Travis; C Y Li; L T Yam; E J Bergstralh; R G Swee
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

8.  Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease.

Authors:  Animesh Pardanani; Terra L Reeder; Teresa K Kimlinger; Jin Y Baek; Chin-Y Li; Joseph H Butterfield; Ayalew Tefferi
Journal:  Leuk Res       Date:  2003-08       Impact factor: 3.156

9.  Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma.

Authors:  Florian Stellmacher; Karl Sotlar; Leopold Balleisen; Peter Valent; Hans-Peter Horny
Journal:  Leuk Lymphoma       Date:  2004-04

10.  Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.

Authors:  H-P Horny; K Sotlar; W R Sperr; P Valent
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411
View more
  3 in total

1.  Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?

Authors:  Antonella Zagaria; Luisa Anelli; Nicoletta Coccaro; Giuseppina Tota; Claudia Brunetti; Angela Minervini; Paola Casieri; Luciana Impera; Crescenzio Francesco Minervini; Annamaria Giordano; Paola Orsini; Cosimo Cumbo; Giorgina Specchia; Francesco Albano
Journal:  Turk J Haematol       Date:  2017-03-29       Impact factor: 1.831

2.  Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case.

Authors:  Sassine Ghanem; Gwenalyn Garcia; Liu Ying; Matthew Hurford; Marcel Odaimi
Journal:  Case Rep Oncol Med       Date:  2016-05-16

3.  Systemic Mastocytosis in Association with Small Lymphocytic Lymphoma.

Authors:  Muhammad F Iqbal; Paolo Marco K Soriano; Sanjai Nagendra; Sherjeel Sana
Journal:  Am J Case Rep       Date:  2017-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.